SCHEMBL647052

SCHEMBL647052

C=CC(=O)C=CCCC=CC(=O)C=CCCCCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.50
PPARG P37231 2/20 0.49
PPARA Q07869 2/20 0.49
TSHR P16473 1/20 0.48
GMNN O75496 1/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
APEX1 P27695 1/20 0.47
CYP2C19 P33261 1/20 0.47
RECQL P46063 1/20 0.47
BLM P54132 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HSD17B10 Q99714 1/20 0.47
DUSP3 P51452 1/20 0.47
MMP2 P08253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL647051 1.00 TOP1 (0.50) TOP1PPARGPPARATSHRGMNN
SCHEMBL6924014 0.96 TSHR (0.52) TOP1PPARGPPARATSHRGMNN
SCHEMBL13452505 0.96 TSHR (0.52) TOP1PPARGPPARATSHRGMNN
SCHEMBL3236379 0.96 TSHR (0.52) TOP1PPARGPPARATSHRGMNN
SCHEMBL6753759 0.96 TSHR (0.52) TOP1PPARGPPARATSHRGMNN
SCHEMBL23093949 0.96 TSHR (0.52) TOP1PPARGPPARATSHRGMNN
SCHEMBL31501794 0.96 TSHR (0.52) TOP1PPARGPPARATSHRGMNN
SCHEMBL3236373 0.96 TSHR (0.52) TOP1PPARGPPARATSHRGMNN
SCHEMBL5925126 0.94 PPARG (0.49) TOP1PPARGPPARATSHRGMNN
SCHEMBL17294081 0.88 TSHR (0.48) PPARGPPARATSHRGMNNUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2070919-B1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION HYKES LAB LLC (JP) 2012-10-10 EP disclosed
US-8119686-B2 Spiroquinone compound and pharmaceutical composition HYKES LABORATORIES LLC (JP) 2012-02-21 US disclosed
US-20100056613-A1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION HYKES LABORATORIES LLC (JP) 2010-03-04 US disclosed
EP-2070919-A1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION Hykes Laboratories LLC (JP) 2009-06-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056613-A1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION NR1H2, NR1H3, APOB TOP1 2795/4885PPARG 471/4885PPARA 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.